Ireland: Medtronic completes acquisition of Intersect ENT

Dublin headquartered Medtronic, a global healthcare technology company, has completed the acquisition of US-based Intersect ENT, a NASDAQ listed medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions. The acquisition adds innovative bioabsorbable steroid-eluting sinus implants to the company’s ENT portfolio. As a result of the close of the…

You must be a HMI Subscriber to view this content.

Subscribe Now »